Microsize Announces a Strategic Investment into The Solubility Company to Accelerate the US Expansion of a Novel, Disruptive Solubility Measuring Technology.
Microsize today announced the strategic investment and partnership with Helsinki-based The Solubility Company.
- Microsize today announced the strategic investment and partnership with Helsinki-based The Solubility Company.
- The technology will benefit Microsize customers who today utilize Microsize services to enhance solubility and bioavailability of drug candidates using particle size engineering including micronization and nanomilling.
- TJ Higley, CEO of Microsize, added: “We couldn’t be more excited to support The Solubility Company in the expansion of this powerful technology to customers stateside.
- “The funding will fuel our strategic expansion into the US, our main market” said Dr. Sami Svanbäck, CEO of The Solubility Company.